Education
About Us
Working with TipRanks
Follow Us
NanoVibronix Inc (NAOV)
NASDAQ:NAOV
NAOV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.92 - $16.25
Previous CloseN/A
Volume412.44K
Average Volume (3M)4.74M
Market Cap
$5.14M
Enterprise ValueN/A
Total Cash (Recent Filing)$101.00K
Total Debt (Recent Filing)$1.95M
Price to Earnings (P/E)―
Beta5.12
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.72
Shares Outstanding759,297
10 Day Avg. Volume9,670,470
30 Day Avg. Volume4,738,049
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.06
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
NanoVibronix News
PremiumMarket News
3 Penny Stocks to Watch Now, 3/18/25
PremiumCompany Announcements
NanoVibronix’s UroShield Study Published in Medical Journal
PremiumCompany Announcements
NanoVibronix Completes Merger with ENvue Medical Holdings---
Ownership Overview
16.53%
Insiders
6.59% Mutual Funds
26.34% Other Institutional Investors
46.73% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NAOV FAQ
What was NanoVibronix Inc’s price range in the past 12 months?
NanoVibronix Inc lowest stock price was $1.92 and its highest was $16.25 in the past 12 months.
What is NanoVibronix Inc’s market cap?
NanoVibronix Inc’s market cap is $5.14M.
When is NanoVibronix Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NanoVibronix Inc’s earnings last quarter?
NanoVibronix Inc released its earnings results on Nov 16, 2021. The company reported -$56.272 earnings per share for the quarter, missing the consensus estimate of N/A by -$56.272.
Is NanoVibronix Inc overvalued?
According to Wall Street analysts NanoVibronix Inc’s price is currently Overvalued.
Does NanoVibronix Inc pay dividends?
NanoVibronix Inc does not currently pay dividends.
What is NanoVibronix Inc’s EPS estimate?
NanoVibronix Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NanoVibronix Inc have?
NanoVibronix Inc has 759,297 shares outstanding.
What happened to NanoVibronix Inc’s price movement after its last earnings report?
NanoVibronix Inc reported an EPS of -$56.272 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.157%.
Which hedge fund is a major shareholder of NanoVibronix Inc?
Currently, no hedge funds are holding shares in NAOV
---
Company Description
NanoVibronix Inc
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
---
NAOV Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---